Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Probing axons using multi-compartmental diffusion in multiple sclerosis.

Bagnato F, Franco G, Li H, Kaden E, Ye F, Fan R, Chen A, Alexander DC, Smith SA, Dortch R, Xu J.

Ann Clin Transl Neurol. 2019 Aug 13. doi: 10.1002/acn3.50836. [Epub ahead of print]

2.

Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.

Romano S, Ferraldeschi M, Bagnato F, Mechelli R, Morena E, Caldano M, Buscarinu MC, Fornasiero A, Frontoni M, Nociti V, Mirabella M, Mayer F, Bertolotto A, Pozzilli C, Vanacore N, Salvetti M, Ristori G.

Front Neurol. 2019 Jul 16;10:695. doi: 10.3389/fneur.2019.00695. eCollection 2019.

3.

Selective inversion recovery quantitative magnetization transfer imaging: Toward a 3 T clinical application in multiple sclerosis.

Bagnato F, Franco G, Ye F, Fan R, Commiskey P, Smith SA, Xu J, Dortch R.

Mult Scler. 2019 Mar 25:1352458519833018. doi: 10.1177/1352458519833018. [Epub ahead of print]

PMID:
30907234
4.

A first investigation of tongue, lip, and jaw movements in persons with dysarthria due to multiple sclerosis.

Mefferd AS, Lai A, Bagnato F.

Mult Scler Relat Disord. 2019 Jan;27:188-194. doi: 10.1016/j.msard.2018.10.116. Epub 2018 Oct 30.

PMID:
30399501
5.

Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.

O'Grady KP, Dula AN, Lyttle BD, Thompson LM, Conrad BN, Box BA, McKeithan LJ, Pawate S, Bagnato F, Landman BA, Newhouse P, Smith SA.

Mult Scler. 2018 Sep 19:1352458518799583. doi: 10.1177/1352458518799583. [Epub ahead of print]

PMID:
30230400
6.

Selective Inversion Recovery Quantitative Magnetization Transfer Brain MRI at 7T: Clinical and Postmortem Validation in Multiple Sclerosis.

Bagnato F, Hametner S, Franco G, Pawate S, Sriram S, Lassmann H, Gore J, Smith SE, Dortch R.

J Neuroimaging. 2018 Jul;28(4):380-388. doi: 10.1111/jon.12511. Epub 2018 Apr 19.

7.

John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy.

Pietropaolo V, Prezioso C, Bagnato F, Antonelli G.

New Microbiol. 2018 Jul;41(3):179-186. Epub 2018 Apr 5. Review.

8.

Optimization of selective inversion recovery magnetization transfer imaging for macromolecular content mapping in the human brain.

Dortch RD, Bagnato F, Gochberg DF, Gore JC, Smith SA.

Magn Reson Med. 2018 Nov;80(5):1824-1835. doi: 10.1002/mrm.27174. Epub 2018 Mar 24.

PMID:
29573356
9.

Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla.

Bagnato F, Hametner S, Boyd E, Endmayr V, Shi Y, Ikonomidou V, Chen G, Pawate S, Lassmann H, Smith S, Welch EB.

PLoS One. 2018 Mar 21;13(3):e0193839. doi: 10.1371/journal.pone.0193839. eCollection 2018.

10.

Multi-compartmental diffusion characterization of the human cervical spinal cord in vivo using the spherical mean technique.

By S, Xu J, Box BA, Bagnato FR, Smith SA.

NMR Biomed. 2018 Apr;31(4):e3894. doi: 10.1002/nbm.3894. Epub 2018 Feb 1.

11.

Alemtuzumab for the treatment of multiple sclerosis.

Evan JR, Bozkurt SB, Thomas NC, Bagnato F.

Expert Opin Biol Ther. 2018 Mar;18(3):323-334. doi: 10.1080/14712598.2018.1425388. Review.

PMID:
29309202
12.

Validating Nonlinear Registration to Improve Subtraction Images for Lesion Detection and Quantification in Multiple Sclerosis.

Kotari V, Salha R, Wang D, Wood E, Salvetti M, Ristori G, Tang L, Bagnato F, Ikonomidou VN.

J Neuroimaging. 2018 Jan;28(1):70-78. doi: 10.1111/jon.12479. Epub 2017 Oct 24.

PMID:
29064129
13.

Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S.

Neurology. 2017 Nov 14;89(20):2092-2100. doi: 10.1212/WNL.0000000000004644. Epub 2017 Oct 13.

14.

Quantitative characterization of optic nerve atrophy in patients with multiple sclerosis.

Harrigan RL, Smith AK, Lyttle B, Box B, Landman BA, Bagnato F, Pawate S, Smith SA.

Mult Scler J Exp Transl Clin. 2017 Sep 13;3(3):2055217317730097. doi: 10.1177/2055217317730097. eCollection 2017 Jul-Sep.

15.

Evaluating single-point quantitative magnetization transfer in the cervical spinal cord: Application to multiple sclerosis.

Smith AK, By S, Lyttle BD, Dortch RD, Box BA, Mckeithan LJ, Thukral S, Bagnato F, Pawate S, Smith SA.

Neuroimage Clin. 2017 Jul 14;16:58-65. doi: 10.1016/j.nicl.2017.07.010. eCollection 2017.

16.

Application and evaluation of NODDI in the cervical spinal cord of multiple sclerosis patients.

By S, Xu J, Box BA, Bagnato FR, Smith SA.

Neuroimage Clin. 2017 May 17;15:333-342. doi: 10.1016/j.nicl.2017.05.010. eCollection 2017.

17.

Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T.

By S, Barry RL, Smith AK, Lyttle BD, Box BA, Bagnato FR, Pawate S, Smith SA.

Magn Reson Med. 2018 Feb;79(2):806-814. doi: 10.1002/mrm.26736. Epub 2017 May 5.

18.

Ultra-high-field (7.0 Tesla and above) MRI is now necessary to make the next step forward in understanding MS pathophysiology - YES.

Bagnato F, Gore JC.

Mult Scler. 2017 Mar;23(3):372-373. doi: 10.1177/1352458516667569. Epub 2016 Dec 16. No abstract available.

PMID:
28260420
19.

Oral Health Literacy: How much Italian people know about the dental hygienist.

Pippi R, Bagnato F, Ottolenghi L.

J Clin Exp Dent. 2017 Jan 1;9(1):e13-e20. doi: 10.4317/jced.52950. eCollection 2017 Jan.

20.

Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.

Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Höftberger R, Berger T, Auff E, Leutmezer F, Trattnig S, Lassmann H, Bagnato F, Hametner S.

Acta Neuropathol. 2017 Jan;133(1):25-42. doi: 10.1007/s00401-016-1636-z. Epub 2016 Oct 27.

21.

The Use of Antiepileptics in Migraine Prophylaxis.

Bagnato F, Good J.

Headache. 2016 Mar;56(3):603-15. doi: 10.1111/head.12781. Epub 2016 Mar 3. Review.

PMID:
26935348
22.

The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.

Haider L, Zrzavy T, Hametner S, Höftberger R, Bagnato F, Grabner G, Trattnig S, Pfeifenbring S, Brück W, Lassmann H.

Brain. 2016 Mar;139(Pt 3):807-15. doi: 10.1093/brain/awv398. Epub 2016 Feb 8.

23.

A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.

Gulati A, Bagnato F, Villoslada P, Velez de Mendizabal N.

CPT Pharmacometrics Syst Pharmacol. 2015 May;4(5):295-304. doi: 10.1002/psp4.36. Epub 2015 Apr 24.

24.

Neurosarcoidosis: diagnosis, therapy and biomarkers.

Bagnato F, Stern BJ.

Expert Rev Neurother. 2015 May;15(5):533-48. doi: 10.1586/14737175.2015.1037288. Review.

PMID:
25936846
25.

7T MRI-Histologic Correlation Study of Low Specific Absorption Rate T2-Weighted GRASE Sequences in the Detection of White Matter Involvement in Multiple Sclerosis.

Bagnato F, Hametner S, Pennell D, Dortch R, Dula AN, Pawate S, Smith SA, Lassmann H, Gore JC, Welch EB.

J Neuroimaging. 2015 May-Jun;25(3):370-8. doi: 10.1111/jon.12238. Epub 2015 Apr 21.

PMID:
25898858
26.

Newer agents in the treatment of multiple sclerosis.

Pawate S, Bagnato F.

Neurologist. 2015 Apr;19(4):104-17. doi: 10.1097/NRL.0000000000000020. Review. Erratum in: Neurologist. 2015 Jul;20(1):22.

PMID:
25888198
27.

Heterogeneity of Multiple Sclerosis White Matter Lesions Detected With T2*-Weighted Imaging at 7.0 Tesla.

Yao B, Ikonomidou VN, Cantor FK, Ohayon JM, Duyn J, Bagnato F.

J Neuroimaging. 2015 Sep-Oct;25(5):799-806. doi: 10.1111/jon.12193. Epub 2015 Feb 6.

28.

Diffuse and focal corticospinal tract disease and its impact on patient disability in multiple sclerosis.

Tovar-Moll F, Evangelou IE, Chiu AW, Auh S, Chen C, Ehrmantraut M, Ohayon JM, Richert N, Bagnato F.

J Neuroimaging. 2015 Mar-Apr;25(2):200-206. doi: 10.1111/jon.12171. Epub 2014 Oct 16.

29.

7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.

Yao B, Hametner S, van Gelderen P, Merkle H, Chen C, Lassmann H, Duyn JH, Bagnato F.

PLoS One. 2014 Oct 10;9(10):e108863. doi: 10.1371/journal.pone.0108863. eCollection 2014.

30.

Evolution of tumefactive lesions in multiple sclerosis: a 12-year study with serial imaging in a single patient.

Ikonomidou VN, Richert ND, Vortmeyer A, Tovar-Moll F, Bielekova B, Cook NE, Duyn JH, Bagnato F.

Mult Scler. 2013 Oct;19(11):1539-43. doi: 10.1177/1352458513498124.

31.

Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.

Velez de Mendizabal N, Hutmacher MM, Troconiz IF, Goñi J, Villoslada P, Bagnato F, Bies RR.

PLoS One. 2013 Sep 5;8(9):e73361. doi: 10.1371/journal.pone.0073361. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/40be1d29-5c85-40a8-a379-666ffd18afdc.

32.

Visualizing iron in multiple sclerosis.

Bagnato F, Hametner S, Welch EB.

Magn Reson Imaging. 2013 Apr;31(3):376-84. doi: 10.1016/j.mri.2012.11.011. Epub 2013 Jan 22. Review.

33.

Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery.

Pellicano C, Kane RL, Gallo A, Xiaobai L, Stern SK, Ikonomidou VN, Evangelou IE, Ohayon JM, Ehrmantraut M, Cantor FK, Bagnato F.

J Neuroimaging. 2013 Jul;23(3):445-52. doi: 10.1111/j.1552-6569.2011.00687.x. Epub 2012 Dec 10.

PMID:
23227967
34.

Cortico-muscular coherence as an index of fatigue in multiple sclerosis.

Tomasevic L, Zito G, Pasqualetti P, Filippi M, Landi D, Ghazaryan A, Lupoi D, Porcaro C, Bagnato F, Rossini P, Tecchio F.

Mult Scler. 2013 Mar;19(3):334-43. doi: 10.1177/1352458512452921. Epub 2012 Jul 3.

PMID:
22760098
35.

Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.

Campbell Z, Sahm D, Donohue K, Jamison J, Davis M, Pellicano C, Auh S, Ohayon J, Frank JA, Richert N, Bagnato F.

Neurology. 2012 May 8;78(19):1493-9. doi: 10.1212/WNL.0b013e3182553bd2. Epub 2012 Apr 25.

36.

Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.

Bagnato F, Hametner S, Yao B, van Gelderen P, Merkle H, Cantor FK, Lassmann H, Duyn JH.

Brain. 2011 Dec;134(Pt 12):3602-15. doi: 10.1093/brain/awr278.

37.

Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging.

Yao B, Bagnato F, Matsuura E, Merkle H, van Gelderen P, Cantor FK, Duyn JH.

Radiology. 2012 Jan;262(1):206-15. doi: 10.1148/radiol.11110601. Epub 2011 Nov 14.

38.

Lesions by tissue specific imaging characterize multiple sclerosis patients with more advanced disease.

Bagnato F, Ikonomidou VN, van Gelderen P, Auh S, Hanafy J, Cantor FK, Ohayon J, Richert N, Duyn J.

Mult Scler. 2011 Dec;17(12):1424-31. doi: 10.1177/1352458511414601. Epub 2011 Jul 29.

PMID:
21803873
39.

Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis.

Vélez de Mendizábal N, Carneiro J, Solé RV, Goñi J, Bragard J, Martinez-Forero I, Martinez-Pasamar S, Sepulcre J, Torrealdea J, Bagnato F, Garcia-Ojalvo J, Villoslada P.

BMC Syst Biol. 2011 Jul 15;5:114. doi: 10.1186/1752-0509-5-114.

40.

Fractal analysis reveals reduced complexity of retinal vessels in CADASIL.

Cavallari M, Falco T, Frontali M, Romano S, Bagnato F, Orzi F.

PLoS One. 2011 Apr 27;6(4):e19150. doi: 10.1371/journal.pone.0019150.

41.

Painful and involuntary multiple sclerosis.

Bagnato F, Centonze D, Galgani S, Grasso MG, Haggiag S, Strano S.

Expert Opin Pharmacother. 2011 Apr;12(5):763-77. doi: 10.1517/14656566.2011.540239. Epub 2011 Feb 17. Review.

42.

T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis.

Bagnato F, Salman Z, Kane R, Auh S, Cantor FK, Ehrmantraut M, Gallo A, Ikonomidou VN, Ohayon J, Pellicano C, Stern SK, McFarland HF.

Mult Scler. 2010 Oct;16(10):1203-12. doi: 10.1177/1352458510377223. Epub 2010 Aug 10.

PMID:
20699284
43.

Quality and quantity of diffuse and focal white matter disease and cognitive disability of patients with multiple sclerosis.

Bomboi G, Ikonomidou VN, Pellegrini S, Stern SK, Gallo A, Auh S, Evangelou IE, Agarwal J, Pellicano C, Ohayon JM, Cantor FK, Ehrmantraut M, McFarland HF, Kane RL, Bagnato F.

J Neuroimaging. 2011 Apr;21(2):e57-63. doi: 10.1111/j.1552-6569.2010.00488.x.

PMID:
20626570
44.

Relationship of cortical atrophy to fatigue in patients with multiple sclerosis.

Pellicano C, Gallo A, Li X, Ikonomidou VN, Evangelou IE, Ohayon JM, Stern SK, Ehrmantraut M, Cantor F, McFarland HF, Bagnato F.

Arch Neurol. 2010 Apr;67(4):447-53. doi: 10.1001/archneurol.2010.48.

PMID:
20385911
45.

Ring and nodular multiple sclerosis lesions: a retrospective natural history study.

Davis M, Auh S, Riva M, Richert ND, Frank JA, McFarland HF, Bagnato F.

Neurology. 2010 Mar 9;74(10):851-6. doi: 10.1212/WNL.0b013e3181d31df5.

46.

Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage.

Riva M, Ikonomidou VN, Ostuni JJ, van Gelderen P, Auh S, Ohayon JM, Tovar-Moll F, Richert ND, Duyn JH, Bagnato F.

AJNR Am J Neuroradiol. 2009 Aug;30(7):1394-401. doi: 10.3174/ajnr.A1573. Epub 2009 Apr 30.

47.

Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging study.

Bagnato F, Yao B, Cantor F, Merkle H, Condon E, Montequin M, Moore S, Quezado M, Tkaczyk D, McFarland H.

J Neurol Sci. 2009 Jul 15;282(1-2):80-5. doi: 10.1016/j.jns.2009.03.021. Epub 2009 Apr 23.

48.

Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T.

Tovar-Moll F, Evangelou IE, Chiu AW, Richert ND, Ostuni JL, Ohayon JM, Auh S, Ehrmantraut M, Talagala SL, McFarland HF, Bagnato F.

AJNR Am J Neuroradiol. 2009 Aug;30(7):1380-6. doi: 10.3174/ajnr.A1564. Epub 2009 Apr 15.

49.

Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.

Bagnato F.

J Neuroimaging. 2009 Jul;19(3):201-4. doi: 10.1111/j.1552-6569.2008.00350.x. Epub 2009 Jan 29. No abstract available.

PMID:
19187471
50.

Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study.

Chiu AW, Richert N, Ehrmantraut M, Ohayon J, Gupta S, Bomboi G, Gaindh D, Cantor FK, Frank JA, McFarland HF, Bagnato F.

Arch Neurol. 2009 Jan;66(1):39-43. doi: 10.1001/archneur.66.1.noc80047. Epub 2008 Nov 10.

PMID:
19001157

Supplemental Content

Loading ...
Support Center